Download
s13054-021-03656-9.pdf 786,77KB
WeightNameValue
1000 Titel
  • Seasonal trends of incidence and outcomes of cardiogenic shock : findings from a large, nationwide inpatients sample with 441,696 cases
1000 Autor/in
  1. Becher, Peter Moritz |
  2. Schrage, Benedikt |
  3. Goßling, Alina |
  4. Fluschnik, Nina |
  5. Seiffert, Moritz |
  6. Westermann, Dirk |
  7. Bernhardt, Alexander M. |
  8. Reichenspurner, Hermann |
  9. Kirchhof, Paulus |
  10. Blankenberg, Stefan |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-09-06
1000 Erschienen in
1000 Quellenangabe
  • 25(1):325
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13054-021-03656-9 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420004/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Outcome data about the use of tranexamic acid (TXA) in civilian patients in mature trauma systems are scarce. The aim of this study was to determine how severely injured patients are affected by the widespread prehospital use of TXA in Germany.!##!Methods!#!The international TraumaRegister DGU® was retrospectively analyzed for severely injured patients with risk of bleeding (2015 until 2019) treated with at least one dose of TXA in the prehospital phase (TXA group). These were matched with patients who had not received prehospital TXA (control group), applying propensity score-based matching. Adult patients (≥ 16) admitted to a trauma center in Germany with an Injury Severity Score (ISS) ≥ 9 points were included.!##!Results!#!The matching yielded two comparable cohorts (n = 2275 in each group), and the mean ISS was 32.4 ± 14.7 in TXA group vs. 32.0 ± 14.5 in control group (p = 0.378). Around a third in both groups received one dose of TXA after hospital admission. TXA patients were significantly more transfused (p = 0.022), but needed significantly less packed red blood cells (p ≤ 0.001) and fresh frozen plasma (p = 0.023), when transfused. Massive transfusion rate was significantly lower in the TXA group (5.5% versus 7.2%, p = 0.015). Mortality was similar except for early mortality after 6 h (p = 0.004) and 12 h (p = 0.045). Among non-survivors hemorrhage as leading cause of death was less in the TXA group (3.0% vs. 4.3%, p = 0.021). Thromboembolic events were not significantly different between both groups (TXA 6.1%, control 4.9%, p = 0.080).!##!Conclusion!#!This is the largest civilian study in which the effect of prehospital TXA use in a mature trauma system has been examined. TXA use in severely injured patients was associated with a significantly lower risk of massive transfusion and lower mortality in the early in-hospital treatment period. Due to repetitive administration, a dose-dependent effect of TXA must be discussed.
1000 Sacherschließung
lokal Female [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Seasons [MeSH]
lokal Hospital Mortality/trends [MeSH]
lokal Humans [MeSH]
lokal Outcome Assessment, Health Care/statistics
lokal Cardiogenic shock
lokal Incidence [MeSH]
lokal Middle Aged [MeSH]
lokal Shock, Cardiogenic/epidemiology [MeSH]
lokal Germany/epidemiology [MeSH]
lokal Outcomes
lokal Shock, Cardiogenic/complications [MeSH]
lokal Outcome Assessment, Health Care/methods [MeSH]
lokal Mortality
lokal Male [MeSH]
lokal Winter
lokal Seasonal trends
lokal Shock, Cardiogenic/mortality [MeSH]
lokal Myocardial infarction
lokal Mechanical circulatory support
lokal Research Letter
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-1221-7015|https://frl.publisso.de/adhoc/uri/U2NocmFnZSwgQmVuZWRpa3Q=|https://frl.publisso.de/adhoc/uri/R2-Dn2xpbmcsIEFsaW5h|https://frl.publisso.de/adhoc/uri/Rmx1c2NobmlrLCBOaW5h|https://frl.publisso.de/adhoc/uri/U2VpZmZlcnQsIE1vcml0eg==|https://frl.publisso.de/adhoc/uri/V2VzdGVybWFubiwgRGlyaw==|https://frl.publisso.de/adhoc/uri/QmVybmhhcmR0LCBBbGV4YW5kZXIgTS4=|https://frl.publisso.de/adhoc/uri/UmVpY2hlbnNwdXJuZXIsIEhlcm1hbm4=|https://frl.publisso.de/adhoc/uri/S2lyY2hob2YsIFBhdWx1cw==|https://frl.publisso.de/adhoc/uri/QmxhbmtlbmJlcmcsIFN0ZWZhbg==
1000 Hinweis
  • DeepGreen-ID: ed66c2f51651428f9f79db43f7c4fe67 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6463949.rdf
1000 Erstellt am 2023-11-15T23:00:59.497+0100
1000 Erstellt von 322
1000 beschreibt frl:6463949
1000 Zuletzt bearbeitet Thu Nov 30 22:41:00 CET 2023
1000 Objekt bearb. Thu Nov 30 22:41:00 CET 2023
1000 Vgl. frl:6463949
1000 Oai Id
  1. oai:frl.publisso.de:frl:6463949 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source